Jaksch Frank L Jr
SEC CIK 1437237 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NAGE | Niagen Bioscience, Inc. | Dir | 281.3K | $11.8K | $230.0K | 3 | 2023-06-12 | 2024-12-13 |
Most active insiders at NAGE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pamir Ozan | CFO | $45.6K | — |
| 2 | Lopez Carlos Luis | SVP, GC | — | — |
| 3 | Fried Robert N | CEO, Dir | — | — |
Jaksch Frank L Jr made no open-market trades at NAGE in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-13 | 2024-12-13 | NAGE | Niagen Bioscience, Inc. | Jaksch Frank L Jr | Dir | M - OptEx | $3.66 | +50.0K | 281.3K | +22% | +$183.0K |
| D | 2024-12-13 | 2024-12-13 | NAGE | Niagen Bioscience, Inc. | Jaksch Frank L Jr | Dir | S - Sale+OE | $6.19 | -37.2K | 244.2K | -13% | -$230.0K |
| 2023-06-13 | 2023-06-12 | NAGE | Niagen Bioscience, Inc. | Jaksch Frank L Jr | Dir | P - Purchase | $1.69 | +7,000 | 231.3K | +3% | +$11.8K |
Purchase Sale Sale after option exercise All abbreviations